ReviewThe international journal of cardiovascular imaging2026
Role of multimodality imaging pre-access for planning of surgical creation of arteriovenous fistulas and arteriovenous grafts in the chronic kidney disease and end-stage renal disease population.
Review in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bilateral peripheral CT venography for evaluating central venous lesions in dysfunctional arteriovenous fistulas: feasibility, safety, and radiation dose in hemodialysis patients.Renal failure · 2026Article
- A narrative review of the role of renal artery intervention in renovascular hypertension.Frontiers in surgery · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review explores a range of imaging techniques used in the pre-surgical planning of vascular access, including duplex ultrasound (DUS), digital subtraction angiography (DSA), digital subtraction venography (DSV), CO2 Venography, magnetic resonance angiography (MRA), computed tomography angiography (CTA), and Intravascular ultrasound (IVUS). For each modality, we analyze its technical background, applications, advantages and disadvantages, and comparisons with alternative imaging options. DUS is the most widely used imaging modality in pre-surgical planning due to its low cost, non-invasiveness, absence of ionizing radiation and nephrotoxic contrast agents, and comparable accuracy in pre-access mapping with other methods. DSA and DSV have high sensitivity and specificity to visualize the arterial and venous system and are recommended when central vascular stenosis is suspected, or a simultaneous intervention is anticipated. However, their use is limited due to exposure to contrast agents and ionizing radiation. CO2-based contrast agents provide an alternative for end-stage renal disease (ESRD) patients to preserve residual renal function. MRA provides a noninvasive option with no radiation exposure and superior image resolution, yet the high cost and limited availability restrict their widespread clinical use. CTA, with its short acquisition time and high-resolution imaging, is a vital modality in intricate cases. However, radiation and contrast exposure can pose challenges in this patient population. The newer IVUS modality has a superior ability to central venous outflow obstruction compared to DSA and provides more information regarding vascular geometry and anatomy. Each imaging modality has its unique advantages and disadvantages in this patient cohort. The decision to use a particular imaging must be made on a case-to-case basis. However, following KDOQI guidelines, a combination of a patient's medical history, physical examination, and DUS is a widely accepted standard practice in pre-surgical vascular access planning, with other imaging modalities reserved for selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.